Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Veterinary parasite vaccines.

G S Cobon1, G Woodrow

  • 1Biotech Australia Pty Limited, Roseville, NSW.

Australasian Biotechnology
|December 1, 1991
PubMed
Summary
This summary is machine-generated.

Biotech Australia is developing novel veterinary parasite vaccines in collaboration with Australian research groups. This overview details their innovative research strategy for these animal health advancements.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biogenesis of mitochondria: Mapping of transcripts from the oli2 region of mitochondrial DNA in two grande strains of Saccharomyces cerevisiae.

Current genetics·2013
Same author

Erratum.

Current genetics·2013
Same author

Successful treatment of fulminant encapsulating peritoneal sclerosis following fungal peritonitis with tamoxifen.

Clinical nephrology·2007
Same author

A randomized controlled trial to determine whether treatment with at neutral pH, low glucose degradation product dialysate (balance) prolongs residual renal function in peritoneal dialysis patients.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2006
Same author

The measurement of total body potassium in patients on peritoneal dialysis.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2002
Same author

An outbreak of vancomycin-resistant enterococci associated with major ward refurbishment.

The Journal of hospital infection·2002
Same journal

The world's first brewery exclusively designed to use continuous fermentation: biotechnology history made in New Zealand.

Australasian biotechnology·1996
Same journal

Production of useful chemicals from sunflower oil by microbial biotransformation with rhizopus stolonifer NRRL 1478.

Australasian biotechnology·1996
Same journal

Industry involvement in Australian agrobiotechnology: the views of scientists.

Australasian biotechnology·1994
Same journal

The 1993 Burnet Lecture. The colony stimulating factors--discovery to clinical use.

Australasian biotechnology·1994
Same journal

Plant biotechnologies in Pacific Rim developing countries: achievements, co-operation and prospects.

Australasian biotechnology·1994
Same journal

Biotechnology in Australia in 1993.

Australasian biotechnology·1994
See all related articles

Area of Science:

  • Veterinary Parasitology
  • Biotechnology
  • Vaccinology

Background:

  • Parasitic infections pose significant threats to animal health and productivity worldwide.
  • The development of effective vaccines is crucial for sustainable livestock management and companion animal care.
  • Biotech Australia Pty Ltd is a leading entity in Australian biotechnology, focusing on innovative solutions.

Purpose of the Study:

  • To provide an overview of novel veterinary parasite vaccines under development.
  • To outline the research strategy employed by Biotech Australia Pty Ltd.
  • To highlight collaborations with Australian research organizations.

Main Methods:

  • Review of ongoing research and development projects.
  • Description of the strategic approach to vaccine discovery and implementation.

Related Experiment Videos

  • Analysis of collaborative research models.

    • Main Results:

    • Identification of key veterinary parasite targets for vaccine development.
    • Elucidation of Biotech Australia's specific research and development pathways.
    • Confirmation of strategic partnerships with Australian research institutions.

    Conclusions:

    • Biotech Australia is advancing the field of veterinary vaccinology through strategic research and development.
    • Collaborative efforts are accelerating the creation of new parasite control solutions.
    • The company's strategy is poised to deliver significant advancements in animal health.